Sheng Zhang
Clinical trials sponsored by Sheng Zhang, explained in plain language.
-
New hope for hard-to-treat cancers: experimental drug targets HER2-positive tumors
Disease control Recruiting nowThis study tests a drug called trastuzumab rezetecan in people with advanced solid tumors that have stopped responding to standard therapies. The drug is given every three weeks to 90 participants divided into three groups based on their cancer type. Researchers will measure how …
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Socks against side effects: simple stockings may shield nerves during chemo
Prevention Recruiting nowThis study tests whether wearing a compression stocking on one foot during antibody-drug conjugate (ADC) infusions can prevent peripheral neuropathy (nerve damage causing numbness or pain). Fifty-eight advanced cancer patients will wear a stocking on their left foot only, while t…
Phase: NA • Sponsor: Sheng Zhang • Aim: Prevention
Last updated Jun 26, 2026 16:56 UTC